RecruitingNCT07017868

Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients


Sponsor

Sohag University

Enrollment

120 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Systemic lupus erythematosus (SLE) is a chronic inflammatory multisystem autoimmune disease characterized by pathogenic autoantibodies production against nuclear structures . SLE affecting mainly women of childbearing age and is characterized by unpredictable flares and remissions. Disease severity varied from a mild episodic disorder to a rapidly progressive life-threatening illness. The kidney is the most commonly involved visceral organ in SLE. Therefore, identifying new noninvasive biomarkers of LN severity and outcome is mandatory. IL-17 is a potent pro-infammatory cytokine that amplifes T-cell activation and stimulates fibroblast cells, endothelial, and epithelial cells to produce several pro-infammatory mediators, including IL-1β, IL-6, and TNF-α. IL-17 receptor signaling enhances the expression of multiple pro-infammatory mediators. Hence, IL-17 enhances the production of neutrophil-attracting chemokines


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • ● Aged ≥18 years.
  • SLE patients fulfilling the SLE International Collaborating Clinics (SLICC) classification criteria and matched controls.
  • Patients cooperative and can answer questions.
  • Patients who are able and willing to give written informed consent

Exclusion Criteria16

  • ● Individuals with other autoimmune diseases.
  • Patients receive any hyperuricemia treatment
  • Pregnancy
  • Malignancy
  • Diabetes.
  • Hypertension.
  • Heart failure.
  • Hepatic diseases.
  • Chronic renal failure other than lupus nephritis.
  • Renal artery stenosis.
  • Renal vein thrombosis.
  • Intrarenal arteriovenous fistula.
  • Obstructive nephropathy.
  • Urinary tract obstruction that could affect RI of intra renal arteries.
  • Uncooperative patients.
  • Patients not able and willing to give written informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTinterleukin- 17

focused on the importance of IL-17 in SLE, and its relation to different disease activity


Locations(1)

Sohag university Hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07017868